Pow-Sang JM - Search Results

1

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors.

Parra NA, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y. Parra NA, et al. Oncotarget. 2018 Dec 14;9(98):37125-37136. doi: 10.18632/oncotarget.26437. eCollection 2018 Dec 14. Oncotarget. 2018. PMID: 30647849 Free PMC article.

2

Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer.

Chen L, Elahi A, Pow-Sang J, Lazarus P, Park J. Chen L, et al. J Urol. 2003 Dec;170(6 Pt 1):2471-4. doi: 10.1097/01.ju.0000087498.23008.bb. J Urol. 2003. PMID: 14634453

3

Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans.

Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Chen L, et al. J Urol. 2006 Jan;175(1):108-12; discussion 112. doi: 10.1016/S0022-5347(05)00042-X. J Urol. 2006. PMID: 16406883

4

Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.

Park JY, Tanner JP, Sellers TA, Huang Y, Stevens CK, Dossett N, Shankar RA, Zachariah B, Heysek R, Pow-Sang J. Park JY, et al. Urology. 2007 Aug;70(2):374-9. doi: 10.1016/j.urology.2007.03.001. Urology. 2007. PMID: 17826523

5

Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.

Park JY, Zheng W, Kim D, Cheng JQ, Kumar N, Ahmad N, Pow-Sang J. Park JY, et al. Cancer Detect Prev. 2007;31(5):359-65. doi: 10.1016/j.cdp.2007.09.002. Epub 2007 Nov 26. Cancer Detect Prev. 2007. PMID: 18037591

6

Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness.

Lin HY, Park HY, Radlein S, Mahajan NP, Sellers TA, Zachariah B, Pow-Sang J, Coppola D, Ganapathy V, Park JY. Lin HY, et al. Urology. 2011 Oct;78(4):971.e1-9. doi: 10.1016/j.urology.2011.04.055. Epub 2011 Jul 29. Urology. 2011. PMID: 21802122 Free PMC article.

7

miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases.

Amankwah EK, Anegbe E, Park H, Pow-Sang J, Hakam A, Park JY. Amankwah EK, et al. Asian J Androl. 2013 Mar;15(2):226-30. doi: 10.1038/aja.2012.160. Epub 2013 Jan 28. Asian J Androl. 2013. PMID: 23353719 Free PMC article.

8

Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study.

Chornokur G, Amankwah EK, Davis SN, Phelan CM, Park JY, Pow-Sang J, Kumar NB. Chornokur G, et al. Prostate Cancer. 2013;2013:384594. doi: 10.1155/2013/384594. Epub 2013 Dec 9. Prostate Cancer. 2013. PMID: 24386569 Free PMC article.

9

Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.

Carastro LM, Lin HY, Park HY, Kim D, Radlein S, Hampton KK, Hakam A, Zachariah B, Pow-Sang J, Park JY. Carastro LM, et al. Prostate Cancer. 2014;2014:129582. doi: 10.1155/2014/129582. Epub 2014 Jul 6. Prostate Cancer. 2014. PMID: 25097786 Free PMC article.

10

Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling.

Gallaher J, Cook LM, Gupta S, Araujo A, Dhillon J, Park JY, Scott JG, Pow-Sang J, Basanta D, Lynch CC. Gallaher J, et al. Clin Exp Metastasis. 2014 Dec;31(8):991-9. doi: 10.1007/s10585-014-9674-1. Epub 2014 Aug 31. Clin Exp Metastasis. 2014. PMID: 25173680 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page